Vedolizumab for acute gastrointestinal graft-versus-host disease: A systematic review and meta-analysis

OBJECTIVE: To determine the safety and efficacy of vedolizumab for the prophylaxis and treatment of gastrointestinal involvement of acute graft-versus-host disease (GVHD) (GI-aGVHD). METHODS: Literature search within PubMed, EMBASE, Web of Science, and Cochrane Library for observational studies and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Allen Cheng-Wei, Dong, Chen, Tay, Soon-Tzeh, Ananthakrishnan, Ashwin, Ma, Kevin Sheng-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692080/
https://www.ncbi.nlm.nih.gov/pubmed/36439135
http://dx.doi.org/10.3389/fimmu.2022.1025350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692080/
https://www.ncbi.nlm.nih.gov/pubmed/36439135
http://dx.doi.org/10.3389/fimmu.2022.1025350

Ejemplares similares